17
Participants
Start Date
September 9, 2016
Primary Completion Date
December 26, 2018
Study Completion Date
December 26, 2018
PF-06840003
Daily Oral PF-06840003
Columbia University Medical Center, New York
Columbia University Medical Center, New York
CUMC Research Pharmacy, New York
Columbia Doctors Tarrytown, Tarrytown
Duke Cancer Center, Durham
Duke University Medical Center, Duke Cancer Center, Durham
University of New Mexico Comprehensive Cancer Center, Albuquerque
UCLA Clinical & Translational Research Center, Los Angeles
UCLA Oncology Center, Los Angeles
UCLA School of Medicine, Los Angeles
Ronald Reagan UCLA Medical Center, Los Angeles
Massachusetts General Hospital, Boston
Brigham & Women's Hospital, Boston
Dana-Farber Cancer Institute, Boston
Lead Sponsor
Pfizer
INDUSTRY